Publikationen von E. Fleer

Unger, C.; Damenz, W.; Fleer, E.; Kim, D. J.; Breiser, A.; Hilgard, P.; Engel, J.; Nagel, G.; Eibl, H. J.: Hexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivo. Acta Oncologica 28 (22), S. 213 - 217 (1989)

Kötting, J.; Fleer, E.; Unger, C.; Eibl, H. J.: Synthetische Alkyllysophospholipide als Antitumormittel - Strukturverwandte des „Platelet Activating Factors”. European Journal of Lipid Science and Technology 90 (9), S. 345 - 351 (1988)

Breiser, A.; Kim, D. J.; Fleer, E.; Damenz, W.; Drube, A.; Berger, M.; Nagel, G. A.; Eibl, H.; Unger, C.: Distribution and metabolism of hexadecylphosphocholine in mice. Lipids 22 (11), S. 925 - 926 (1987)

Fleer, E.; Unger, C.; Kim, D. J.; Eibl, H.: Metabolism of ether phospholipids and analogs in neoplastic cells. Lipids 22 (11), S. 856 - 861 (1987)

Neumüller, W.; Fleer, E.; Unger, C.; Eibl, H.: Enzymatic acylation of ether and ester lysophospholipids in rat liver microsomes. Lipids 22 (11), S. 800 - 812 (1987)

Unger, C.; Eibl, H.; Kim, D. J.; Fleer, E.; Kötting, J.; Bartsch, H. H.; Nagel, G. A.; Pfizenmaier, K.: Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities. Journal of the National Cancer Institute 78 (2), S. 219 - 222 (1987)

Fleer, E.: Ether lipids and analogues. Seminar of the 19th German Cancer Congress, Frankfurt/Main, 1988. Journal of Cancer Research and Clinical Oncology 114 (6), S. 655 - 656 (1988)

Fleer, E.; Kim, D. J.; Unger, C.; Eibl, H.: 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phospho[3H-methyl]choline: Clinical preparation and metabolism in leukemic Raji cells. International symposium on the synthesis and applications of isotopically labeled compounds 1985. Proceedings of the 2nd Int. Symposium, S. 473 - 478 (1986)